WallStreetZen

NYSE: ATIP
ATI Physical Therapy Inc Stock Forecast, Predictions & Price Target

Analyst price target for ATIP

Based on 2 analysts offering 12 month price targets for ATI Physical Therapy Inc.
Min Forecast
$5.00+48.81%
Avg Forecast
$5.00+48.81%
Max Forecast
$5.00+48.81%

Should I buy or sell ATIP stock?

Based on 4 analysts offering ratings for ATI Physical Therapy Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
4 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ATIP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Barrington Research
Bottom 4%
4
HoldDowngradesN/AN/A2021-07-27
Benchmark
Top 6%
95
HoldDowngradesN/AN/A2021-07-27
Citigroup
Top 32%
69
HoldDowngrades$5.00+48.81%2021-07-27
Jefferies
Top 18%
83
HoldDowngrades$5.00+48.81%2021-07-27
Anonymous
Citigroup
Strong BuyInitiates Coverage On$11.00+227.38%2021-07-12

1 of 1

Forecast return on equity

Is ATIP forecast to generate an efficient return?
Company
-1.99%
Industry
4.52%
Market
37.5%
ATIP's Return on Equity is forecast to be low in 3 years (-1.99%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ATIP forecast to generate an efficient return on assets?
Company
-0.63%
Industry
0.08%
ATIP is forecast to generate lower Return on Assets (-0.63%) than the US Medical Care Facilities industry average (0.08%)
Forecast

ATIP earnings per share forecast

What is ATIP's earnings per share in the next 3 years based on estimates from 1 analysts?
Avg 1 year Forecast
-$0.20-99.04%
Avg 2 year Forecast
-$0.09-99.57%
Avg 3 year Forecast
$0.00-100%

ATIP revenue forecast

What is ATIP's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$628.4M-28.73%
Avg 2 year Forecast
$669.2M-24.09%
Avg 3 year Forecast
$736.2M-16.49%
ATIP's revenue is forecast to grow at a rate of -5.83% per year, which is not exceptional
Forecast

ATIP revenue growth forecast

How is ATIP forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
-5.83%
Industry
6.87%
Market
10.08%
ATIP's revenues are forecast to grow slower (-5.83% per year) than the US Medical Care Facilities industry average (6.87%)
Forecast
ATIP's revenues are forecast to grow slower (-5.83% per year) than the US market average (10.08%)
Forecast

ATI Physical Therapy Stock Forecast FAQ

Is ATI Physical Therapy Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: ATIP) stock is to Hold ATIP stock.

Out of 4 analysts, 0 (0%) are recommending ATIP as a Strong Buy, 0 (0%) are recommending ATIP as a Buy, 4 (100%) are recommending ATIP as a Hold, 0 (0%) are recommending ATIP as a Sell, and 0 (0%) are recommending ATIP as a Strong Sell.

What is ATIP's earnings growth forecast for 2021-2023?

(NYSE: ATIP) ATI Physical Therapy's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 1.34%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.37%.

ATI Physical Therapy's earnings in 2021 is -$794,210,423.On average, 1 Wall Street analysts forecast ATIP's earnings for 2021 to be $-39,450,881, with the lowest ATIP earnings forecast at $-39,450,881, and the highest ATIP earnings forecast at $-39,450,881. On average, 2 Wall Street analysts forecast ATIP's earnings for 2022 to be $-17,752,897, with the lowest ATIP earnings forecast at $-43,395,969, and the highest ATIP earnings forecast at $5,917,632.

In 2023, ATIP is forecast to generate $0 in earnings, with the lowest earnings forecast at $-27,615,617 and the highest earnings forecast at $27,615,617.

What is ATIP's revenue growth forecast for 2021-2023?

(NYSE: ATIP) ATI Physical Therapy's forecast annual revenue growth rate of -5.83% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.87%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.

ATI Physical Therapy's revenue in 2021 is $881,623,000.On average, 2 Wall Street analysts forecast ATIP's revenue for 2021 to be $123,949,540,116, with the lowest ATIP revenue forecast at $123,737,688,884, and the highest ATIP revenue forecast at $124,161,391,348. On average, 2 Wall Street analysts forecast ATIP's revenue for 2022 to be $132,006,988,092, with the lowest ATIP revenue forecast at $129,892,026,351, and the highest ATIP revenue forecast at $134,122,147,088.

In 2023, ATIP is forecast to generate $145,222,441,531 in revenue, with the lowest revenue forecast at $142,240,152,167 and the highest revenue forecast at $148,204,928,150.

What is ATIP's forecast return on assets (ROA) for 2021-2024?

(NYSE: ATIP) forecast ROA is -0.63%, which is lower than the forecast US Medical Care Facilities industry average of 0.08%.

What is ATIP's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ATIP price target, the average ATIP price target is $5.00, with the highest ATIP stock price forecast at $5.00 and the lowest ATIP stock price forecast at $5.00.

On average, Wall Street analysts predict that ATI Physical Therapy's share price could stay at $5.00 by Jul 27, 2022. The average ATI Physical Therapy stock price prediction forecasts a potential downside of N/A from the current ATIP share price of $3.36.

What is ATIP's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: ATIP) ATI Physical Therapy's current Earnings Per Share (EPS) is -$20.94. On average, analysts forecast that ATIP's EPS will be $-0.20 for 2021, with the lowest EPS forecast at $-0.20, and the highest EPS forecast at $-0.20. On average, analysts forecast that ATIP's EPS will be $-0.09 for 2022, with the lowest EPS forecast at $-0.22, and the highest EPS forecast at $0.03. In 2023, ATIP's EPS is forecast to hit $0.00 (min: $-0.14, max: $0.14).

What is ATIP's forecast return on equity (ROE) for 2021-2024?

(NYSE: ATIP) forecast ROE is -1.99%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.